Ritholtz Wealth Management Acquires New Stake in Waters Co. (NYSE:WAT)

Ritholtz Wealth Management bought a new stake in shares of Waters Co. (NYSE:WATFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 637 shares of the medical instruments supplier’s stock, valued at approximately $210,000.

Several other institutional investors also recently bought and sold shares of WAT. Vanguard Group Inc. boosted its stake in shares of Waters by 0.5% in the first quarter. Vanguard Group Inc. now owns 6,689,208 shares of the medical instruments supplier’s stock valued at $2,076,263,000 after purchasing an additional 30,274 shares during the period. Bank of New York Mellon Corp boosted its holdings in Waters by 1.4% in the third quarter. Bank of New York Mellon Corp now owns 3,520,629 shares of the medical instruments supplier’s stock valued at $965,392,000 after purchasing an additional 48,740 shares during the period. State Street Corp grew its stake in Waters by 1.2% during the 2nd quarter. State Street Corp now owns 2,619,676 shares of the medical instruments supplier’s stock worth $698,248,000 after purchasing an additional 29,920 shares in the last quarter. Alliancebernstein L.P. increased its holdings in Waters by 37.2% during the 2nd quarter. Alliancebernstein L.P. now owns 2,018,487 shares of the medical instruments supplier’s stock worth $538,008,000 after purchasing an additional 547,777 shares during the period. Finally, Wellington Management Group LLP raised its position in Waters by 79.6% in the 1st quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock valued at $467,011,000 after purchasing an additional 666,851 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Down 1.4 %

Waters stock opened at $339.69 on Wednesday. The stock has a 50-day simple moving average of $335.16 and a 200-day simple moving average of $301.21. The company has a market capitalization of $20.11 billion, a P/E ratio of 31.31, a PEG ratio of 6.85 and a beta of 0.92. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.57 and a current ratio of 2.22. Waters Co. has a fifty-two week low of $231.90 and a fifty-two week high of $363.80.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, beating the consensus estimate of $3.56 by $0.06. The business had revenue of $819.50 million during the quarter, compared to the consensus estimate of $815.50 million. Waters had a return on equity of 81.30% and a net margin of 21.72%. The company’s revenue was down 4.5% compared to the same quarter last year. During the same period in the prior year, the company earned $3.84 earnings per share. Equities research analysts expect that Waters Co. will post 11.89 earnings per share for the current year.

Insider Buying and Selling at Waters

In other news, Director Linda Baddour sold 500 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total transaction of $177,770.00. Following the completion of the sale, the director now owns 2,250 shares in the company, valued at $799,965. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.77% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Stifel Nicolaus upped their target price on shares of Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research note on Wednesday, February 7th. Wolfe Research initiated coverage on shares of Waters in a research report on Wednesday, December 13th. They set a “peer perform” rating for the company. Citigroup boosted their target price on shares of Waters from $265.00 to $300.00 and gave the stock a “neutral” rating in a research note on Monday, December 11th. Barclays lifted their price target on Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a report on Monday, February 12th. Finally, TheStreet upgraded Waters from a “c+” rating to a “b-” rating in a report on Wednesday, December 13th. One research analyst has rated the stock with a sell rating and seven have given a hold rating to the stock. According to MarketBeat, Waters has an average rating of “Hold” and an average target price of $293.50.

Read Our Latest Report on WAT

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.